StreetAlpha.app
Home › Stocks › CRL

Charles River Laboratories International, Inc. (CRL)

Healthcare
$332.11
▼ −1.05%
LAST CLOSE · NOV 17

Charles River Laboratories provides research models and drug testing services to pharmaceutical and other life science companies. It last closed at $332.11 on Nov 17, down 1.05% on the day. The average 12-month price target from 10 analysts is $346.80 (+4.4% from the last close), with a high of $400.00 and a low of $295.00. Analyst consensus is Strong Buy, based on the latest ratings from 10 firms (9 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 4 whale options trades in CRL, 25% of them bullish and 75% bearish. In the past 30 days there were 12 dark pool prints totaling $16.7M, the largest $7.4M.

AI Auto Pilots
Is CRL in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$4.0B
−1.2% vs a year ago
Net income
$40.2M
1.0% margin
EPS (diluted)
$0.92
Free cash flow
$399.6M
10.0% margin
Valuation
Market cap
$15.9B
47.9M shares
P/E
361.0
Price over 12 month EPS
Price to sales
4.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$200.4M
At Sep 26
Shareholder equity
$3.2B
Buybacks
$324.2M
Last 12 months
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $3.5B$3.5BFY2021FY2022: $4.0B$4.0BFY2022FY2023: $4.1B$4.1BFY2023FY2024: $4.0B$4.0BFY2024FY2025: $4.0B$4.0BFY2025

From CRL's SEC filings, latest 10-Q for the period ending Sep 26, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 10 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
10firms
9 Buy1 Hold0 Sell
Each firm's latest rating on CRL in the past 90 days
Average 12-month target
$346.80
▲ 4.4% upside

Based on 10 analysts who set a price target on CRL in the past 90 days. The average target is $346.80, with a high of $400.00 and a low of $295.00, compared with the last close of $332.11.

Low $295.00Avg $346.80High $400.00
Blue marker: last close $332.11
Highest target$400.00
Average target$346.80
Lowest target$295.00
Latest rating changes
UBSTarget raised
Nov 6Buy$357 → $387
RBC CapitalTarget raised
Nov 5Buy$322 → $352
BarclaysTarget raised
Nov 5Buy$330 → $375
Evercore ISI GroupTarget raised
Nov 5Buy$330 → $400
Morgan StanleyTarget raised
Oct 13Buy$300 → $340
DateFirmActionRatingPrice target
Nov 6UBSTarget raisedBuy$357 → $387
Nov 5RBC CapitalTarget raisedBuy$322 → $352
Nov 5BarclaysTarget raisedBuy$330 → $375
Nov 5Evercore ISI GroupTarget raisedBuy$330 → $400
Oct 13Morgan StanleyTarget raisedBuy$300 → $340
Loading…

Technical Analysis

CRL · as of the Nov 17 close · updated after every close
Uptrend

The stock sits between its 20 and 50 day averages. It is 31% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 50). The nearest support is the Pivot S1 at $328.49, and the nearest resistance the swing high (Oct 6) at $333.30.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 4.7%/day
Key levels
$379.6352 week high+14.3%
$345.5620 day average+4.0%
$338.54Pivot R1+1.9%
$334.93Pivot+0.8%
$333.30Swing high (Oct 6)+0.4%
$332.11Last close
$328.49Pivot S1−1.1%
$326.29Swing low (Nov 12)−1.8%
$313.0450 day average−5.7%
$284.48100 day average−14.3%
$228.93200 day average−31.1%
$146.2052 week low−56.0%
Indicators
RSI (14)50.01Middle of its rangeNeutral
MACD6.07Below its signal lineBearish
Stochastic34.7Middle of its rangeNeutral
ADX (14)25.2Trending up
Williams %R-69.9Oversold below −80, overbought above −20Neutral
CCI (20)-66.8Oversold below −100, overbought above 100Neutral
Rate of change−5.6%Change over 10 sessionsBearish
ATR (14)$15.48Typical daily range, 4.7% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for CRL

What happened before

See how CRL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Whale flow leans bearish1 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow CRL usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CRL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
4
Bullish
1
25%
Bearish
3
75%
Date span
Sep 24 – Oct 29
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
12
Notional
$16.7M
Largest print
$7.4M
Loading…

CRL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●293 buying vs 301 selling
  • ▼Held by funds -8.9 pts
  • ▲Funds holding +71
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding642571+12.4%
In funds' top 1065+20.0%
Held by funds110.0%118.8%−8.9 pts
New / increased133 / 16074 / 193+9.7%
Reduced / sold out242 / 59199 / 63+14.9%
Put/call ratio1.002.27−56.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CRL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CRL Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$324.2M
2.0% yield
Left in program
$700.0M
4.4% of value
Shares outstanding, 12 months
−2.6%
Fewer shares
Last quarter
$102K
Sep 2026
Avg price paid, last quarter
$241.04
424 shares bought
S&P 500 rank by spending
#308 of 358
 
Spent each quarter, last 3 yearsTop bar $353.1M
Dec 2023: $116K, average price $195.86Mar 2024: $9.3M, average price $220.65Jun 2024: $9.0M, average price $216.94Sep 2024: $100.8M, average price $201.36Dec 2024: $86K, average price $199.06Mar 2025: $353.1M, average price $169.29Jun 2025: $6.8M, average price $136.11Sep 2025: $94K, average price $162.60Dec 2025: $96K, average price $174.81Mar 2026: $208.3M, average price $177.31Jun 2026: $112.4M, average price $173.57Sep 2026: $102K, average price $241.04
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CRL is in one of them and how their past CRL trades turned out.

CRL in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CRL in an article yet. Here's the latest on the wider market.

CRL Congress Trades

All congress trades →
Trades, 12 months
2
Buys
2
100%
Sells
0
0%
People
1
Last filed Jun 9
Who traded CRL · since 2018
Latest 5 filings of 41
$1K – $15KTraded May 15, 2026Filed Jun 9, 2026
$1K – $15KTraded Jan 29, 2026Filed Feb 6, 2026
$1K – $15KTraded Apr 28, 2025Filed Sep 9, 2025
$15K – $50KTraded May 12, 2025Filed Jun 22, 2025
$15K – $50KTraded May 8, 2025Filed Jun 22, 2025
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KMay 15, 2026Jun 9, 202625 d
Ro KhannaD · CABuy$1K – $15KJan 29, 2026Feb 6, 20268 d
Lori Chavez-DeRemerExecutive branchSell$1K – $15KApr 28, 2025Sep 9, 2025134 d
Jefferson ShreveR · INSell$15K – $50KMay 12, 2025Jun 22, 202541 d
Jefferson ShreveR · INBuy$15K – $50KMay 8, 2025Jun 22, 202545 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Charles River Laboratories International

Charles River Laboratories provides research models, laboratory testing and other services that help companies develop new drugs before they are tested in people. Its work spans early drug discovery, safety assessment and some support for manufacturing. Its customers include large drug and biotechnology companies, contract research organizations, chemical and consumer product firms, hospitals, universities and government agencies around the world. The company is based in Wilmington, Massachusetts.

Headquarters
Wilmington, MA
Founded
1947